Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem vs Imipenem in Ventilator-Associated Pneumonia
NCT00211016Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of doripenem in ventilator-associated pneumonia (VAP), sponsored by Johnson & Johnson. Started Aug 2004; status: completed.
02
Drugs
doripenem
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT00211016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211016.